ENG/中
老虎证券
行情
交易
收费
下载
优惠与活动
帮助
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
股权激励
关于
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
LeonaBio Inc
9.02
0.0000
成交量:
3.17万
成交额:
28.84万
市值:
8,420.98万
市盈率:
-0.93
高:
9.53
开:
9.34
低:
8.93
收:
9.02
52周最高:
14.21
52周最低:
2.20
股本:
933.59万
流通股本:
256.85万
量比:
0.21
换手率:
1.23%
股息:
- -
股息率:
- -
每股收益(TTM):
-9.6552
每股收益(LYR):
-25.1917
净资产收益率:
-89.42%
总资产收益率:
-42.21%
市净率:
3.14
市盈率(LYR):
-0.36
数据加载中...
总览
公司
新闻资讯
公告
公司资料
公司名字:
LeonaBio Inc
交易所:
NASDAQ
成立时间:
2011
员工人数:
26
公司地址:
18706 North Creek Parkway,Suite 104,Bothell,Washington,United States
官网:
http://www.leonabio.com
邮编:
98011
电话:
425 620 8501
传真:
- -
简介:
LeonaBio, Inc.于2011年3月31日在华盛顿州注册成立为M3 Biotechnology,Inc.,并于2015年10月27日在特拉华州重新注册为股份公司。该公司是一家处于临床后期阶段的生物制药公司,致力于开发小型药物分子来恢复神经元健康并阻止神经变性。其主要药物候选者lasofoxifene和ATH-1105是新型小分子疗法,旨在针对当前治疗选择有限或无效的破坏性疾病。LeonaBio 坚持追求科学卓越和以患者为中心的创新,致力于为最需要帮助的人开发具有实际意义的新疗法。
董事
名称
职位
Leen Kawas
President, Chief Executive Officer and Director
Tadataka Yamada
Chairman of the Board
James A. Johnson
Director
John M. Fluke, Jr.
Director
Joseph Edelman
Director
股东
名称
职位
Leen Kawas
President, Chief Executive Officer and Director
Mark Litton
Chief Operating Officer
Glenna Mileson
Chief Financial Officer and Corporate Secretary
Hans Moebius
Chief Medical Officer
Kevin Church
Vice President of Discovery
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券 | 轻松买卖美股港股A股/美债/ETF/Crypto/期权期货","description":"老虎证券提供多项优惠:港股&Crypto 0佣、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投,免费实时行情与多种工具,立即开户享更多优惠!","keywords":"老虎证券,老虎证券开户,老虎证券香港,老虎证券登录,老虎证券官网,香港证券开户,证券公司开户,股票开户,香港证券公司,香港证券,证券公司,股票投资,投资app,投资平台,股票买卖,股票交易平台,股票app,证券app,新手投资","social":{"ogDescription":"老虎证券提供多项优惠:港股&Crypto 0佣、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投,免费实时行情与多种工具,立即开户享更多优惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/LONA/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LONA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LONA\",,,,,undefined,":{"symbol":"LONA","market":"US","secType":"STK","nameCN":"LeonaBio Inc","latestPrice":9.02,"timestamp":1774464018959,"preClose":9.02,"halted":0,"volume":31696,"delay":0,"changeRate":0,"floatShares":2568500,"shares":9335900,"eps":-9.65516,"marketStatus":"交易中","change":0,"latestTime":"03-25 14:43:49 EDT","open":9.34,"high":9.525,"low":8.93,"amount":288368.274544,"amplitude":0.065965,"askPrice":9.56,"askSize":3,"bidPrice":8.8,"bidSize":5,"shortable":3,"etf":0,"ttmEps":-9.65516,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1774468800000},"marketStatusCode":2,"adr":0,"listingDate":1600401600000,"exchange":"NASDAQ","adjPreClose":9.02,"postHourTrading":{"tag":"盘后","latestPrice":9.02,"preClose":9.02,"latestTime":"19:29 EDT","volume":31,"amount":280.52,"timestamp":1774394943720,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.207687},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LONA\",,,,,undefined,":{"symbol":"LONA","floatShares":2568500,"roa":"-42.21%","roe":"-89.42%","lyrEps":-25.191731,"volumeRatio":0.207687,"shares":9335900,"dividePrice":0,"high":9.525,"amplitude":0.065965,"preClose":9.02,"low":8.93,"week52Low":2.1955,"pbRate":"3.14","week52High":14.21,"institutionHeld":0,"latestPrice":9.02,"committee":0.25,"eps":-9.65516,"divideRate":0,"volume":31696,"delay":0,"ttmEps":-9.65516,"open":9.34,"prevYearClose":7.57,"prevWeekClose":9.92,"prevMonthClose":5.63,"prevQuarterClose":7.57,"fiveDayClose":9.78,"twentyDayClose":5.81,"sixtyDayClose":7.48},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LONA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-06","symbol":"LONA","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"post","actualEps":-1.68},{"market":"US","date":"2025-09-18","symbol":"LONA","defaultRemindTime":1758202200000,"type":"split","dateTimestamp":1758168000000,"forFactor":10,"toFactor":1,"ratio":10},{"market":"US","date":"2025-08-07","symbol":"LONA","fiscalQuarterEnding":"2025/06","expectedEps":-0.18,"name":null,"time":"盘后","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"post","actualEps":-0.18},{"market":"US","date":"2025-05-09","symbol":"LONA","fiscalQuarterEnding":"2025/03","expectedEps":-0.2,"name":null,"time":"盘后","type":"earning","dateTimestamp":1746763200000,"reportTimeType":"post","actualEps":-0.23},{"market":"US","date":"2025-02-27","symbol":"LONA","fiscalQuarterEnding":"2024/12","expectedEps":-0.23,"name":null,"time":"盘后","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"post","actualEps":-0.39}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LONA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LONA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.6667,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1772596800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LONA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LONA","date":"2026-03-24","current":-0.934215,"percent":0.083333,"low":-2.796591,"twenty":-1.574484,"median":-1.329,"eighty":-1.121606,"high":-0.637746,"avg":-1.380907,"sd":0.492156,"marketCap":87477504},"quantilePoints":[{"date":"2026-01-16","current":-0.662315,"twenty":-0.686048,"median":-0.684271,"eighty":-0.675175,"marketCap":24984524},{"date":"2026-01-23","current":-1.56325,"twenty":-0.686675,"median":-0.673032,"eighty":-0.651338,"marketCap":58970481},{"date":"2026-01-30","current":-1.165659,"twenty":-1.344824,"median":-0.68793,"eighty":-0.65761,"marketCap":43972150},{"date":"2026-02-06","current":-1.185458,"twenty":-1.276038,"median":-1.158235,"eighty":-0.670888,"marketCap":44719023},{"date":"2026-02-13","current":-1.158234,"twenty":-1.22753,"median":-1.158234,"eighty":-0.684166,"marketCap":43692072},{"date":"2026-02-20","current":-1.368597,"twenty":-1.23248,"median":-1.158234,"eighty":-0.68542,"marketCap":51627598},{"date":"2026-02-27","current":-1.390871,"twenty":-1.374537,"median":-1.170609,"eighty":-0.765162,"marketCap":52467831},{"date":"2026-03-06","current":-1.329,"twenty":-1.392851,"median":-1.185458,"eighty":-1.076564,"marketCap":50133852},{"date":"2026-03-13","current":-1.856145,"twenty":-1.437398,"median":-1.225055,"eighty":-1.089928,"marketCap":70019347},{"date":"2026-03-20","current":-2.457536,"twenty":-1.517584,"median":-1.326525,"eighty":-1.109727,"marketCap":92705616},{"date":"2026-03-24","current":-2.318943,"twenty":-1.574484,"median":-1.329,"eighty":-1.121606,"marketCap":87477504}],"updateTime":1774436675652},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":266015004,"yearFounded":2011,"employeeNum":26,"address":"18706 North Creek Parkway,Suite 104,Bothell,Washington,United States","zipCode":"98011","officePhone":"425 620 8501"},"stockCompanyDetail":{"websiteUrl":"http://www.leonabio.com","stockEarnings":[{"period":"1week","weight":-0.2018},{"period":"1month","weight":0.6223},{"period":"3month","weight":0.251},{"period":"6month","weight":1.3675},{"period":"1year","weight":1.6529},{"period":"ytd","weight":0.1915}],"compareEarnings":[{"period":"1week","weight":-0.0263},{"period":"1month","weight":-0.0526},{"period":"3month","weight":-0.0539},{"period":"6month","weight":-0.0074},{"period":"1year","weight":0.1378},{"period":"ytd","weight":-0.0421}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"LeonaBio, Inc.于2011年3月31日在华盛顿州注册成立为M3 Biotechnology,Inc.,并于2015年10月27日在特拉华州重新注册为股份公司。该公司是一家处于临床后期阶段的生物制药公司,致力于开发小型药物分子来恢复神经元健康并阻止神经变性。其主要药物候选者lasofoxifene和ATH-1105是新型小分子疗法,旨在针对当前治疗选择有限或无效的破坏性疾病。LeonaBio 坚持追求科学卓越和以患者为中心的创新,致力于为最需要帮助的人开发具有实际意义的新疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.081093},{"month":2,"riseRate":0.5,"avgChangeRate":-0.02158},{"month":3,"riseRate":0.333333,"avgChangeRate":0.021182},{"month":4,"riseRate":0.4,"avgChangeRate":-0.068964},{"month":5,"riseRate":0.6,"avgChangeRate":0.065626},{"month":6,"riseRate":0.4,"avgChangeRate":-0.221545},{"month":7,"riseRate":0.6,"avgChangeRate":0.106269},{"month":8,"riseRate":0.4,"avgChangeRate":-0.034355},{"month":9,"riseRate":0.2,"avgChangeRate":-0.224006},{"month":10,"riseRate":0.5,"avgChangeRate":0.036994},{"month":11,"riseRate":0.666667,"avgChangeRate":0.141696},{"month":12,"riseRate":0.666667,"avgChangeRate":0.280766}],"exchange":"NASDAQ","name":"LeonaBio Inc","nameEN":"LeonaBio Inc"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"LONA\",market:\"US\",,,undefined,":{"directors":[{"name":"Leen Kawas","position":"President, Chief Executive Officer and Director"},{"name":"Tadataka Yamada","position":"Chairman of the Board"},{"name":"James A. Johnson","position":"Director"},{"name":"John M. Fluke, Jr.","position":"Director"},{"name":"Joseph Edelman","position":"Director"}],"executives":[{"name":"Leen Kawas","position":"President, Chief Executive Officer and Director"},{"name":"Mark Litton","position":"Chief Operating Officer"},{"name":"Glenna Mileson","position":"Chief Financial Officer and Corporate Secretary"},{"name":"Hans Moebius","position":"Chief Medical Officer"},{"name":"Kevin Church","position":"Vice President of Discovery"}]}}}